Medical prescriptions falsified by the patients: a 12‐year national monitoring to assess prescription drug diversion
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Diversion of prescription drugs is difficult to assess in quality and quantity. This study aimed to characterize diversion of prescription drugs in France through a comparative analysis of falsified prescriptions collected during three periods from 2001 to 2012. The data recorded in a national program which records all falsified prescriptions presented to community pharmacies were studied. Included data regarded: subjects, prescription forms, and drugs. Description of the dataset in three periods (2001–2004, 2005–2008, and 2009–2012) was completed with clustering analyses to characterize profiles of prescriptions and subjects associated with the most reported drugs. The 4469 falsified prescriptions concerned most often females (51.6%). Average age was 46.5 years. Zolpidem, bromazepam, and buprenorphine were the most frequent drugs. Alone, 13 drugs (1.7%, 13/772) represented more than 40% of the total reports (3055/7272). They were associated with three diversion profiles: (i) buprenorphine, flunitrazepam, and morphine were mentioned on overlapping secure prescription forms presented by young men; (ii) alprazolam, bromazepam, zolpidem, codeine/acetaminophen were mentioned on simple prescription forms presented by experienced women; and (iii) acetaminophen and lorazepam were mentioned on modified prescription forms presented by elderly subjects. Clonazepam, clorazepate, dextropropoxyphene, zopiclone moved between those profiles. The patterns of falsified prescriptions provided in this study contribute to enhance the scientific knowledge on the most diverted prescription drugs. The latter follow distinct trajectories across time depending on their pharmacology (including their abuse/addiction potential) and on their regulation's history. The close and continuous analysis of falsified prescriptions is an excellent way to monitor prescription drug diversion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116
DSM-5 criteria for substance use disorders: recommendations and rationale
Hasin, D. S., O’Brien, C. P., Auriacombe, M., Borges, G., Bucholz, K., Budney, A., Compton, W. M., Crowley, T., Ling, W., Petry, N. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12060782 · Cited by 1,622
Hajak, G., Müller, W. E., Wittchen, H. U., Pittrow, D., & Kirch, W. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00491.x · Cited by 404
Han, B., Compton, W. M., Jones, C. M., & Cai, R. (2015) · JAMA · doi:10.1001/jama.2015.11859 · Cited by 366
Victorri‐Vigneau, C., Dailly, E., Veyrac, G., & Jolliet, P. (2007) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2007.02861.x · Cited by 201
Pharmacoepidemiological characterisation of zolpidem and zopiclone usage
Victorri-Vigneau, C., Feuillet, F., Wainstein, L., Grall-Bronnec, M., Pivette, J., Chaslerie, A., Sébille, V., & Jolliet, P. (2013) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-013-1557-x · Cited by 49
Research works printed but not linked: 45
- 10.1038/clpt.2010.154 · DOI · Paper page
- 10.1097/AJP.0000000000000021 · DOI · Paper page
- 10.1186/2197-1714-1-9 · DOI
- 10.2105/AJPH.2014.301966 · DOI · Paper page
- 10.1002/pds.3711 · DOI · Paper page
- 10.1016/j.socscimed.2014.10.016 · DOI
- 10.1186/s40621-017-0118-7 · DOI
- 10.1111/j.1472-8206.2011.00950.x · DOI
- 10.1007/s40264-016-0497-7 · doi:10.1007/s40264-016-0497-7
- 10.1007/s002280050246 · DOI
- 10.1007/s00228-001-0412-7 · DOI
- 10.2165/00002018-200730030-00007 · DOI
- 10.1159/000356812 · DOI
- 10.1111/j.1472-8206.2010.00882.x · DOI
- Nordmann S., 2013, Doctor shopping reveals geographical variations in opioid abuse, Pain Physician, 16, 89
- 10.1159/000346179 · DOI
- 10.2515/therapie/2015012 · DOI
- 10.2515/therapie/2014221 · doi:10.2515/therapie/2014221
- 10.1214/aos/1176344552 · DOI · Paper page
- 10.1016/j.csda.2007.09.023 · DOI · Paper page
- 10.1017/S0305004100013517 · DOI · Paper page
- 10.18637/jss.v025.i01 · DOI · Paper page
- R Development Core Team, R: a language and environment for statistical computing
- American psychiatric association (APA), 2013, Diagnostic and statistical manual of mental disorders (DSM‐5), 991, 10.1176/appi.books.9780890425596 · DOI · Paper page
- 10.2515/therapie/2015009 · DOI
- Daveluy A., 2018, Tamper‐resistant prescription forms for narcotics in France:should we generalise them? Fundam, Clin. Pharmacol.
- 10.1111/fcp.12024 · DOI
- 10.1002/pds.4123 · DOI
- 10.1016/j.euroneuro.2015.07.006 · DOI
- 10.1111/pme.12391 · DOI
- 10.1177/0269881112471155 · DOI
- 10.5694/mja12.10986 · DOI
- Rigg K.K., 2012, Patterns of prescription medication diversion among drug dealers, Drugs (Abingdon Engl.), 19, 144
- 10.2515/therapie:2003069 · DOI
- 10.2165/11531570-000000000-00000 · DOI
- ANSM : Agence nationale de sécurité du médicament et des produits de santé.Arret de commercialisation Rohypnol (flunitrazepam) [Internet]. 2013 [last accessed 26/12/2017]. Available from: file:///C:/Users/jouanjus/AppData/Local/Temp/pi‐130419‐Rohypnol.pdf · doi:10.1016/j.jpp.2012.10.003
- 10.1007/s00228-014-1783-x · DOI
- 10.1159/000377628 · DOI
- 10.1097/YIC.0b013e32834967e5 · DOI
- Rubio González V., 2016, Hospital emergencies associated with the consumption of hypnotics and sedatives, 2009–2013, Castilla y León, Spain, Rev. Esp. Salud Publica, 90, e1
- 10.1080/10826084.2016.1201509 · doi:10.1080/10826084.2016.1201509
- 10.1111/fcp.12210 · doi:10.1111/fcp.12210
- 10.1371/journal.pone.0076499 · DOI
- Delcourt N., 2017, Recreational antitussive and antihistamine drug poisoning in adolescents and young adults reported to a French Poison Control Center (Oral communication published as an Abstract in the Special Issue: Abstracts of the Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, 19–21 April 2017, Rouen, France), Fundam. Clin. Pharmacol., 31, 14
- 10.1111/j.1472-8206.2008.00661.x · doi:10.1111/j.1472-8206.2008.00661.x
Cited by
Schifano, F., Chiappini, S., Corkery, J. M., & Guirguis, A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz007 · Cited by 194
Roussin, A., Soeiro, T., Fouque, C., Jouanjus, E., Frauger, E., Fouilhé, N., Mallaret, M., Micallef, J., Lapeyre‐Mestre, M., & the French Addictovigilance Network (FAN) (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15323 · Cited by 38
“OSIAP (‘Suspicious prescription form indicators of possible abuse’) programme, which investigates medicines identified on forged pre- scriptions presented in pharmacies.18,21 From 2001 to 2004, a national network of volunteer community pharmacies was implemented on a national level to collect suspect prescriptions dur…”
BackgroundSelf-citationCarvalho, F., Tonon, A. C., Hidalgo, M. P., Martins Costa, M., & Mengue, S. S. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1405838 · Cited by 4
Metadata
- Authors
- Jouanjus, E., Guernec, G., Lapeyre‐Mestre, M., & the French Addictovigilance Network
- Venue
- Fundamental & Clinical Pharmacology
- Publisher
- Wiley
- Published
- 2018-04-02
- Volume
- 32
- Issue
- 3
- Pages
- 306-322
- ISSN
- 0767-3981 (ISSN-L)
- 1472-8206
- OpenAlex
- W2791301177
- Cited by
- 61
- References
- 6
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.